Study for Diabetes & Hypertension Prevalence Launched - Express Healthcare: "Study for Diabetes & Hypertension Prevalence Launched
India's largest study to estimate diabetes and hypertension prevalence amongst outpatients across 10 states
Aventis Pharma Limited (Group sanofi-aventis) recently announced the launch of Screening India's Twin Epidemic (SITE), a cross-sectional study that aims to estimate the prevalence of diagnosed and undiagnosed cases of diabetes and hypertension in outpatient settings in major cities across India. The study will involve 1,000 general practitioners including consultant physicians and over 20,000 patients from 10 states, namely Maharashtra, New Delhi, West Bengal, Tamil Nadu, Andhra Pradesh, Karnataka, Gujarat, Uttar Pradesh, Rajasthan and Madhya Pradesh; making it one of the largest study of its kind in India. The study was commissioned by sanofi-aventis with the aim of quantifying and increasing awareness amongst medical professionals and patients on the lurking likelihood of a twin epidemic of diabetes and hypertension."
Click on link above for full article.